Correvio Pharma Corp (CORV) Stock Analyst Ratings
NASDAQ:CORV - Nasdaq -
ChartMill assigns a Buy % Consensus number of 60% to CORV. The Buy consensus is the weighted average rating of the current analysts ratings.
CORV was analyzed by 3 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about CORV.
In the previous month the buy percentage consensus was at a similar level.
Only 3 analysts analyzed CORV. So this is just the average opinion of a couple of analysts.